Medical Device News Magazine

Integrated Endoscopy Announces the Global Launch of Gen II Nuvis Single-Use, 4K, Battery Operated Cordless Arthroscope

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Integrated Endoscopy, a medical device company pioneering the development of 4K, low-cost, single-use endoscopes for the arthroscopic surgery market, today announced the launch of its second generation NUVIS (pronounced “nu-vee”) Single-Use Arthroscope, a first-of-its-kind 4K endoscope designed for use in arthroscopic surgical procedures.

The release of the Gen II NUVIS features a patent-pending simplified optical train design that reduces the number of optical elements by over 60% while boosting image quality to 4K.  Not only is the image quality superior, but the Gen II NUVIS will also be substantially faster and less expensive to manufacture and amenable to high-volume automation.  As part of the Gen II launch, Integrated Endoscopy is releasing multiple versions of NUVIS to make the technology compatible with most cannulas on the market.  NUVIS is also compatible with most installed video towers and will support a 4K camera system without requiring additional capital equipment.  NUVIS has a built-in battery powered LED, which eliminates the light box and bulky light cord.

“The release of the Gen II NUVIS is a huge milestone for the company in terms of image quality and compatibility, said Brad Sharp, Integrated Endoscopy’s CEO. “Our nextgen arthroscope also provides a substantial decrease in manufacturing costs while simultaneously increasing ease of manufacturability. The demand we have seen for NUVIS far exceeds our current manufacturing capacity, so the efficiencies the Gen II NUVIS affords will greatly aid in shortening production time and costs.  With a global market of over 1.5 million units per month, increasing our manufacturing capacity will be a major focus for the company moving forward.”

Integrated Endoscopy’s Gen II NUVIS single-use, 4K, battery operated cordless arthroscope is FDA 501(k) cleared, CE marked, and is being registered in a number of markets around the world.  As manufacturing capacity increases, the company will continue to expand its global distribution network to provide this unique technology to the arthroscopic surgical community.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”